Skip to content
healthcare.dev
Get a free key

CVS Maximum Redness Relief

NDC 51316-837, Glycerin, Naphazoline HCI, solution/ drops, from CVS Pharmacy, Inc..

Product NDC
51316-837
Status
Listed
Labeler
CVS Pharmacy, Inc.
Dosage form
SOLUTION/ DROPS
Route
OPHTHALMIC
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M018
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51316-837 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPHAZOLINE HYDROCHLORIDE.03 g/100mL
  • GLYCERIN.5 g/100mL

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Chemical Allergen [EPC]

Package NDCNDC-11Package
51316-837-01513160837011 BOTTLE, DROPPER in 1 BOX (51316-837-01) / 15 mL in 1 BOTTLE, DROPPER

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 51316-837 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51316-837 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51316-837. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.